AstraZeneca Imfinzi combo improves survival in bladder cancer study
Summary: AstraZeneca announced that its immunotherapy drug Imfinzi (durvalumab), in...
Sources on this story
Reported by 1 sources, including:
- Seeking Alpha
More AI-scored stories
- Poland proposes joint Patriot missile production with Ukraine and US
- Romania shoots down drone breaching its airspace, president says
- Ramaphosa wins high court bid to block Parliament's impeachment inquiry
- National Council backs renewed push for resolving Cyprus problem
- Trump Prepares Strong Move Against Putin, but a Striking Detail Emerges: What Is Happening
- Monsoon to Become Active in Varanasi on July 27: 60 Small Temples Submerged as Ganga Water Level Rises, Ganga Aarti Venue Shifted from Lalita Ghat
- Chile Sanitary Services Chief Calls for Higher Infrastructure Standards After Storms
- Iran Claims Attack on Amazon Data Center in Bahrain